Baseline Plasma Levels of Interleukin-8 in Stage IV Non-Small-Cell Lung Cancer Patients: Relationship With Nutritional Status and Prognosis

REFERENCES

• Non-Small Cell Lung Cancer Collaborative Group . 2010 . Chemotherapy and supportive care versus supportive care alone in advanced non-small cell lung cancer . Cohrane Database Syst Rev , 5 : CD007309
   Google Scholar
• Leonard , E J and Yoshimura , T . 1990 . Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]) . Am J Respir Cell Mol Biol , 2 : 479 – 486 .
   PubMed Web of Science ®Google Scholar
• Smith , D R , Polverini , P J , Kunkel , S L , Orringer , M B Whyte , R I . 1994 . Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma . J Exp Med , 179 : 1409 – 1415 .
   PubMed Web of Science ®Google Scholar
• Arenberg , D A , Kunkel , S L , Polverini , P J , Glass , M Burdick , M D . 1996 . Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice . J Clin Invest , 97 : 2792 – 2802 .
   PubMed Web of Science ®Google Scholar
• Koch , A E , Polverini , P J , Kunkel , S L , Harlow , L A DiPietro , L A . 1992 . Interleukin-8 (IL-8) as a macrophage-derived mediator of angiogenesis . Science , 258 : 1798 – 1801 .
   PubMed Web of Science ®Google Scholar
• Strieter , R M , Kunkel , S L , Elner , V M , Martonyi , C L Koch , A E . 1992 . Interleukin-8: a corneal factor that induces neovascularization . Am J Pathol , 141 : 1279 – 1284 .
   PubMed Web of Science ®Google Scholar
• Hu , D E , Hori , Y and Fan , T PD . 1993 . Interleukin-8 stimulates angiogenesis in rats . Inflammation , 17 : 135 – 143 .
   PubMed Web of Science ®Google Scholar
• Macchiarini , P , Fontanini , G , Hardin , M J , Squartini , F and Angeletti , C A . 1992 . Relation of neovascularization to metastasis of non-small-cell lung cancer . Lancet , 340 : 145 – 146 .
   PubMed Web of Science ®Google Scholar
• Weidner , N , Carroll , P R , Flax , J , Blumenfeld , W and Folkman , J . 1993 . Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma . Am J Pathol , 143 : 401 – 409 .
   PubMed Web of Science ®Google Scholar
• Weidner , N , Semple , J P , Welch , W R and Folkman , J . 1991 . Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma . N Engl J Med , 324 : 1 – 8 .
   PubMed Web of Science ®Google Scholar
• Zhu , Y M , Webster , S J , Flower , D and Woll , P J . 2004 . Interleukin-8/CXCL8 is a growth factor for human lung cancer cells . Br J Cancer , 91 : 1970 – 1976 .
   PubMed Web of Science ®Google Scholar
• Pfitzenmaier , J , Vessella , R , Higano , C S , Noteboom , J L Wallace , D Jr. 2003 . Elevation of cytokine levels in cachectic patients with prostate carcinoma . Cancer , 97 : 1211 – 1216 .
   PubMed Web of Science ®Google Scholar
• Song , B , Zhang , D , Wang , S , Zheng , H and Wang , X . 2009 . Association of interleukin-8 with cachexia from patients with low-third gastric cancer . Comp Funct Genomics , 212 : 212345 – 212350 .
   Google Scholar
• Krzystek-Korpacka , M , Matusiewicz , M , Diakowska , D , Grabowski , K Blachut , K . 2007 . Impact of weight loss on circulating IL-1, IL-6, IL-8, TNF-alpha, VEGF-A, VEGF-C and midkine in gastroesophageal cancer patients . Clin Biochem , 40 : 1353 – 1360 .
   PubMed Web of Science ®Google Scholar
• Kosacka , M , Weryńska , B , Gołecki , M , Jankowska , R and Passowicz-Muszyńska , E . 2008 . The incidence and pathogenesis of cancer anorexia-cachexia syndrome in lung cancer . Pneumonol Alergol Pol , 76 : 360 – 365 .
   PubMedGoogle Scholar
• Orditura , M , De Vita , F , Catalano , G , Infusino , S Lieto , E . 2002 . Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: relationship with prognosis . J Interferon Cytokine Res , 22 : 1129 – 1135 .
   PubMed Web of Science ®Google Scholar
• Kaminska , J , Kowalska , M , Kotowicz , B , Fuksiewicz , M Glogowski , M . 2006 . Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF—an independent prognostic factor . Oncology , 70 : 115 – 125 .
   PubMed Web of Science ®Google Scholar
• Boldrini , L , Gisfredi , S , Ursino , S , Lucchi , M Mussi , A . 2005 . Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations . Lung Cancer , 50 : 309 – 317 .
   PubMed Web of Science ®Google Scholar
• Nestlé Nutrition Institute . “ MNA Mini Nutritional Assessment ” . Retrieved from http://www.mna-elderly.com/
   Google Scholar
• Huhmann , M B and Cunningham , R S . 2005 . Importance of nutritional screening in treatment of cancer-related weight loss . Lancet Oncol , 6 : 334 – 343 .
   PubMed Web of Science ®Google Scholar
• Council on Practice Quality Management Committee . 1994 . Identifying patients at risk: ADA's definitions for nutrition screening and nutrition assessment . J Am Diet Assoc , 94 : 838 – 839 .
   PubMedGoogle Scholar
• Gioulbasanis , I , Baracos , V E , Giannousi , Z , Xyrafas , A Martin , L . 2011 . Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment (MNA) versus weight loss history . Ann Oncol , 22 : 835 – 841 .
   PubMed Web of Science ®Google Scholar
• Therasse , P , Arbuck , S G , Eisenhauer , E A , Wanders , J Kaplan , R S . 2000 . New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada . J Natl Cancer Institute , 92 : 205 – 216 .
   PubMed Web of Science ®Google Scholar
• Oken , M M , Creech , R H , Tormey , D C , Horton , J Davis , T E . 1982 . Toxicity and response criteria of the Eastern Cooperative Oncology Group . Am J Clin Oncol , 5 : 649 – 655 .
   PubMed Web of Science ®Google Scholar
• Berthier , F , Lambert , C , Genin , C and Bienvenu , J . 1999 . Evaluation of an automated immunoassay method for cytokine measurement using the Immulite Immunoassay system . Clin Chem Lab Med , 37 : 593 – 599 .
   PubMed Web of Science ®Google Scholar
• Martin , C . 2000 . “ Calorie, protein, fluid, and micronutrient requirements ” . In The Clinical Guide to Oncology Nutrition , Edited by: McCallum , P and Polisena , C . 45 – 60 . Chicago : The American Dietetic Association .
   Google Scholar
• Muscaritoli , M , Bossola , M , Aversa , Z , Bellantone , R and Rossi Fanelli , F . 2006 . Prevention and treatment of cancer cachexia: new insights into and old problem . Eur J Cancer , 42 : 31 – 41 .
   PubMed Web of Science ®Google Scholar
• Gordon , J , Green , S and Goggin , P . 2005 . Cancer cachexia . QJM , 98 : 779 – 788 .
   PubMed Web of Science ®Google Scholar
• Tisdale , M . 2009 . Mechanisms of cancer cachexia . Physiol Rev , 89 : 381 – 410 .
   PubMed Web of Science ®Google Scholar
• Yang , Z G , Blaha , V , Meguid , M M , Laviano , A Oler , A . 1999 . Interleukin-1 alpha injection into ventromedial hypothalamic nucleus of normal rats depresses food intake and increases release of dopamine and serotonin . Pharmacol Biochem Behav , 62 : 61 – 65 .
   PubMed Web of Science ®Google Scholar
• Ramos , E J , Suzuki , S , Marks , D , Inui , A Asakawa , A . 2004 . Cancer anorexia-cachexia syndrome: cytokines and neuropeptides . Curr Opin Nutr Metab Care , 7 : 427 – 434 .
   PubMed Web of Science ®Google Scholar
• Illman , J , Corringham , R , Robinson , D Jr. , Davis , H M Rossi , J F . 2005 . Are inflammatory cytokines the common link between cancer-associated cachexia and depression? . J Support Oncol , 3 : 37 – 50 .
   PubMedGoogle Scholar
• Carson , J A and Baltgalvis , K A . 2010 . Interleukin 6 as a key regulator of muscle mass during cachexia . Exerc Sport Sci Rev , 38 : 168 – 176 .
   PubMed Web of Science ®Google Scholar
• Trikha , M , Corringham , R , Klein , B and Rossi , J F . 2003 . Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence . Clin Cancer Res , 9 : 4653 – 4665 .
   PubMed Web of Science ®Google Scholar
• Watchorn , T M , Waddell , I and Ross , J A . 2002 . Proteolysis-inducing factor differentially influences transcriptional regulation in endothelial subtypes . Am J Physiol Endocrinol Metab , 282 : E763 – E769 .
   PubMed Web of Science ®Google Scholar
• Watchorn , T M , Dowidar , N , Dejong , C H , Waddell , I D Garden , O J . 2005 . The cachectic mediator proteolysis inducing factor activates NF-kB and STAT3 in human Kupffer cells and monocytes . Int J Oncol , 27 : 1105 – 1111 .
   PubMed Web of Science ®Google Scholar
• Williams , M L , Torres-Duarte , A , Brant , L J , Bhargava , P Marshall , J . 2004 . The relationship between a urinary cachectic factor and weight loss in advanced cancer patients . Cancer Invest , 22 : 866 – 870 .
   PubMed Web of Science ®Google Scholar
• Wieland , B M , Stewart , G D , Skipworth , R J , Sangster , K Fearon , K C . 2007 . Is there a human homologue to the murine proteolysis-inducing factor? . Clin Cancer Res , 13 : 4984 – 4992 .
   PubMed Web of Science ®Google Scholar
• Weryńska , B , Kosacka , M , Gołecki , M and Jankowska , R . 2006 . VEGF in the cancer anorexia-cachexia syndrome in patients with lung cancer . Pneumonol Alergol Pol , 74 : 186 – 190 .
   PubMedGoogle Scholar